Vascular surveillance by haptotactic blood platelets in inflammation and infection.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 11 2020
Historique:
received: 27 12 2019
accepted: 14 10 2020
entrez: 14 11 2020
pubmed: 15 11 2020
medline: 25 11 2020
Statut: epublish

Résumé

Breakdown of vascular barriers is a major complication of inflammatory diseases. Anucleate platelets form blood-clots during thrombosis, but also play a crucial role in inflammation. While spatio-temporal dynamics of clot formation are well characterized, the cell-biological mechanisms of platelet recruitment to inflammatory micro-environments remain incompletely understood. Here we identify Arp2/3-dependent lamellipodia formation as a prominent morphological feature of immune-responsive platelets. Platelets use lamellipodia to scan for fibrin(ogen) deposited on the inflamed vasculature and to directionally spread, to polarize and to govern haptotactic migration along gradients of the adhesive ligand. Platelet-specific abrogation of Arp2/3 interferes with haptotactic repositioning of platelets to microlesions, thus impairing vascular sealing and provoking inflammatory microbleeding. During infection, haptotaxis promotes capture of bacteria and prevents hematogenic dissemination, rendering platelets gate-keepers of the inflamed microvasculature. Consequently, these findings identify haptotaxis as a key effector function of immune-responsive platelets.

Identifiants

pubmed: 33188196
doi: 10.1038/s41467-020-19515-0
pii: 10.1038/s41467-020-19515-0
pmc: PMC7666582
doi:

Substances chimiques

Actin-Related Protein 2-3 Complex 0
Lipopolysaccharides 0
Fibrinogen 9001-32-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5778

Commentaires et corrections

Type : ErratumIn

Références

Machlus, K. R. & Italiano, J. E. Jr. The incredible journey: from megakaryocyte development to platelet formation. J. Cell Biol. 201, 785–796 (2013).
pubmed: 23751492 pmcid: 3678154
Sreeramkumar, V. et al. Neutrophils scan for activated platelets to initiate inflammation. Science 346, 1234–1238 (2014).
pubmed: 25477463 pmcid: 4280847
Ho-Tin-Noé, B., Boulaftali, Y. & Camerer, E. Platelets and vascular integrity: how platelets prevent bleeding in inflammation. Blood 131, 277–288 (2018).
pubmed: 29191915
Semple, J. W., Italiano, J. E. Jr. & Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264–274 (2011).
pubmed: 21436837
Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463–469 (2007).
pubmed: 17384648
Gaertner, F. & Massberg, S. Patrolling the vascular borders: platelets in immunity to infection and cancer. Nat. Rev. Immunol. 19, 747–760 (2019).
Hillgruber, C. et al. Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia. J. Exp. Med. 212, 1255–1266 (2015).
pubmed: 26169941 pmcid: 4516803
Gros, A. et al. Single platelets seal neutrophil-induced vascular breaches via GPVI during immune complex-mediated inflammation in mice. Blood 126, 1017–1026 (2015).
Koupenova, M., Clancy, L., Corkrey, H. A. & Freedman, J. E. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ. Res. 122, 337–351 (2018).
pubmed: 29348254 pmcid: 5777300
Furie, B. & Furie, B. C. Mechanisms of thrombus formation. N. Engl. J. Med. 359, 938–949 (2008).
pubmed: 18753650
Zuchtriegel, G. et al. Platelets guide leukocytes to their sites of extravasation. PLoS Biol. 14, e1002459 (2016).
pubmed: 27152726 pmcid: 4859536
Majno, G., Palade, G. E. & Schoefl, G. I. Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J. Biophys. Biochem. Cytol. 11, 607–626 (1961).
pubmed: 14468625 pmcid: 2225127
Marchesi, V. T. Some electron microscopic observations on interactions between leukocytes, platelets, and endothelial cells in acute inflammation. Ann. NY Acad. Sci. 116, 774–788 (1964).
pubmed: 14212852
Petrie, R. J., Doyle, A. D. & Yamada, K. M. Random versus directionally persistent cell migration. Nat. Rev. Mol. Cell. Biol. 10, 538–549 (2009).
pubmed: 19603038 pmcid: 2752299
Graham, D. M. et al. Enucleated cells reveal differential roles of the nucleus in cell migration, polarity, and mechanotransduction. J. Cell Biol. 217, 895–914 (2018).
pubmed: 29351995 pmcid: 5839789
Gaertner, F. et al. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 171, 1368–1382 (2017).
pubmed: 29195076
Krause, M. & Gautreau, A. Steering cell migration: lamellipodium dynamics and the regulation of directional persistence. Nat. Rev. Mol. Cell. Biol. 15, 577–590 (2014).
pubmed: 25145849
Lehtimaki, J., Hakala, M. & Lappalainen, P. Actin filament structures in migrating cells. Handb. Exp. Pharmacol. 235, 123–152 (2017).
pubmed: 27469496
Case, L. B. & Waterman, C. M. Integration of actin dynamics and cell adhesion by a three-dimensional, mechanosensitive molecular clutch. Nat. Cell Biol. 17, 955 (2015).
pubmed: 26121555 pmcid: 6300998
Yamada, K. M. & Sixt, M. Mechanisms of 3D cell migration. Nat. Rev. Mol. Cell. Biol. 20, 738–752 (2019).
pubmed: 31582855
Allen, R. D. et al. Transformation and motility of human platelets: details of the shape change and release reaction observed by optical and electron microscopy. J. Cell Biol. 83, 126–142 (1979).
pubmed: 511936
Paul, D. S. et al. Deletion of the Arp2/3 complex in megakaryocytes leads to microthrombocytopenia in mice. Blood Adv. 1, 1398–1408 (2017).
pubmed: 29104956 pmcid: 5667565
Kahr, W. H. A. et al. Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. Nat. Commun. 8, 14816 (2017).
pubmed: 28368018 pmcid: 5382316
Schurr, Y. et al. Platelet lamellipodium formation is not required for thrombus formation and stability. Blood 134, 2318–2329 (2019).
pubmed: 31697813
Wu, C. et al. Arp2/3 is critical for lamellipodia and response to extracellular matrix cues but is dispensable for chemotaxis. Cell 148, 973–987 (2012).
pubmed: 22385962 pmcid: 3707508
Suraneni, P. et al. The Arp2/3 complex is required for lamellipodia extension and directional fibroblast cell migration. J. Cell Biol. 197, 239–251 (2012).
pubmed: 22492726 pmcid: 3328382
Swaney, K. F. & Li, R. Function and regulation of the Arp2/3 complex during cell migration in diverse environments. Curr. Opin. Cell Biol. 42, 63–72 (2016).
pubmed: 27164504 pmcid: 5342243
Carter, S. B. Haptotaxis and the mechanism of cell motility. Nature 213, 256–260 (1967).
Swaminathan, V., Fischer, R. S. & Waterman, C. M. The FAK-Arp2/3 interaction promotes leading edge advance and haptosensing by coupling nascent adhesions to lamellipodia actin. Mol. Biol. Cell 27, 1085–1100 (2016).
pubmed: 26842895 pmcid: 4814217
Rotty, J. D. et al. Arp2/3 complex is required for macrophage integrin functions but is dispensable for FcR phagocytosis and in vivo motility. Dev. Cell 42, 498–513 (2017).
pubmed: 28867487 pmcid: 5601320
Nesbitt, W. S. et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat. Med. 15, 665–673 (2009).
pubmed: 19465929
Samson, A. L. et al. Endogenous fibrinolysis facilitates clot retraction in vivo. Blood 130, 2453–2462 (2017).
Lam, W. A. et al. Mechanics and contraction dynamics of single platelets and implications for clot stiffening. Nat. Mater. 10, 61–66 (2011).
pubmed: 21131961
Qiu, Y. et al. Platelet mechanosensing of substrate stiffness during clot formation mediates adhesion, spreading, and activation. Proc. Natl Acad. Sci. USA 111, 14430–14435 (2014).
pubmed: 25246564 pmcid: 4210024
Hetrick, B., Han, M. S., Helgeson, L. A. & Nolen, B. J. Small molecules CK-666 and CK-869 inhibit actin-related protein 2/3 complex by blocking an activating conformational change. Chem. Biol. 20, 701–712 (2013).
pubmed: 23623350 pmcid: 3684959
Renkawitz, J. et al. Adaptive force transmission in amoeboid cell migration. Nat. Cell Biol. 11, 1438–1443 (2009).
pubmed: 19915557
Carter, S. B. Haptotaxis and the mechanism of cell motility. Nature 213, 256–260 (1967).
pubmed: 6030602
Nourshargh, S. & Alon, R. Leukocyte migration into inflamed tissues. Immunity 41, 694–707 (2014).
pubmed: 25517612
Wang, S. et al. Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J. Exp. Med. 203, 1519–1532 (2006).
pubmed: 16754715 pmcid: 2118318
Goerge, T. et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 111, 4958–4964 (2008).
pubmed: 18256319 pmcid: 2384127
Rayes, J. et al. The contribution of platelet glycoprotein receptors to inflammatory bleeding prevention is stimulus and organ dependent. Haematologica 103, e256–e258 (2018).
pubmed: 29419432 pmcid: 6058802
Grommes, J. et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung. Injury 185, 628–636 (2012).
Kleinschnitz, C. et al. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 115, 2323–2330 (2007).
pubmed: 17438148
Falet, H., Hoffmeister, K. M., Neujahr, R. & Hartwig, J. H. Normal Arp2/3 complex activation in platelets lacking WASp. Blood 100, 2113–2122 (2002).
pubmed: 12200375
Veltman, D. M., King, J. S., Machesky, L. M. & Insall, R. H. SCAR knockouts in Dictyostelium: WASP assumes SCAR’s position and upstream regulators in pseudopods. J. Cell Biol. 198, 501–508 (2012).
pubmed: 22891261 pmcid: 3514037
Lemichez, E., Lecuit, M., Nassif, X. & Bourdoulous, S. Breaking the wall: targeting of the endothelium by pathogenic bacteria. Nat. Rev. Microbiol. 8, 93 (2010).
pubmed: 20040916
Wong, C. H., Jenne, C. N., Petri, B., Chrobok, N. L. & Kubes, P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 14, 785–792 (2013).
pubmed: 23770641 pmcid: 4972575
Claushuis, T. A. et al. Platelet glycoprotein VI aids in local immunity during pneumonia-derived sepsis caused by gram-negative bacteria. Blood 131, 864–876 (2018).
pubmed: 29187378
Li, M. et al. MRSA epidemic linked to a quickly spreading colonization and virulence determinant. Nat. Med. 18, 816 (2012).
pubmed: 22522561 pmcid: 3378817
Labandeira-Rey, M. et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315, 1130–1133 (2007).
pubmed: 17234914
Ali, R. A., Wuescher, L. M., Dona, K. R. & Worth, R. G. Platelets mediate host defense against Staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities. J. Immunol. 198, 344–351 (2017).
pubmed: 27895175
White, J. G. Current concepts of platelet structure. Am. J. Clin. Pathol. 71, 363–378 (1979).
pubmed: 375715
Gong, H. et al. G protein subunit Gα13 binds to integrin αIIbβ3 and mediates integrin “outside-in” signaling. Science 327, 340–343 (2010).
pubmed: 20075254 pmcid: 2842917
Liu, S. et al. Binding of paxillin to α 4 integrins modifies integrin-dependent biological responses. Nature 402, 676 (1999).
pubmed: 10604475
Hartwig, J. H. et al. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 82, 643–653 (1995).
pubmed: 7664343
Massberg, S. et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 94, 3829–3838 (1999).
pubmed: 10572098
Savage, B. & Ruggeri, Z. M. Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets. J. Biol. Chem. 266, 11227–11233 (1991).
pubmed: 2040630
Schwarz Henriques, S., Sandmann, R., Strate, A. & Koster, S. Force field evolution during human blood platelet activation. J. Cell Sci. 125, 3914–3920 (2012).
pubmed: 22582082
Zhang, Y. et al. Platelet integrins exhibit anisotropic mechanosensing and harness piconewton forces to mediate platelet aggregation. Proc. Natl Acad. Sci. USA 115, 325–330 (2018).
pubmed: 29269394
Elosegui-Artola, A. et al. Mechanical regulation of a molecular clutch defines force transmission and transduction in response to matrix rigidity. Nat. Cell Biol. 18, 540 (2016).
pubmed: 27065098
Tweedy, L., Susanto, O. & Insall, R. H. Self-generated chemotactic gradients—cells steering themselves. Curr. Opin. Cell Biol. 42, 46–51 (2016).
pubmed: 27105308
Thomas, S. G. et al. The actin binding proteins cortactin and HS1 are dispensable for platelet actin nodule and megakaryocyte podosome formation. Platelets 28, 372–379 (2017).
pubmed: 27778524
Sereni, L., Castiello, M. C. & Villa, A. Platelets in Wiskott-Aldrich syndrome: victims or executioners? J. Leukoc. Biol. 103, 577–590 (2018).
pubmed: 28851742
Beristain-Covarrubias, N. et al. Salmonella-induced thrombi in mice develop asynchronously in the spleen and liver and are not effective bacterial traps. Blood 133, 600–604 (2019).
pubmed: 30401709 pmcid: 6474721
Levi, M. & Ten Cate, H. Disseminated intravascular coagulation. N. Engl. J. Med. 341, 586–592 (1999).
pubmed: 10451465
Nicolai, L., Gaertner, F. & Massberg, S. Platelets in host defense: experimental and clinical insights. Trends Immunol. 40, 922–938 (2019).
pubmed: 31601520
Tiedt, R., Schomber, T., Hao-Shen, H. & Skoda, R. C. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109, 1503–1506 (2007).
pubmed: 17032923
Riedl, J. et al. Lifeact mice for studying F-actin dynamics. Nat. Methods 7, 168 (2010).
pubmed: 20195247
Snippert, H. J. et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem. Cells Cell 143, 134–144 (2010).
pubmed: 20887898
Snapper, S. B. et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9, 81–91 (1998).
pubmed: 9697838
Kanaji, T., Russell, S. & Ware, J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood 100, 2102–2107 (2002).
pubmed: 12200373
Emambokus, N. R. & Frampton, J. The glycoprotein IIb molecule is expressed on early murine hematopoietic progenitors and regulates their numbers in sites of hematopoiesis. Immunity 19, 33–45 (2003).
pubmed: 12871637
Kim, I. H. et al. Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities. J. Neurosci. 33, 6081–6092 (2013).
pubmed: 23554489 pmcid: 3656411
Wang, P.-S. et al. Crucial roles of the Arp2/3 complex during mammalian corticogenesis. Development 143, 2741–2752 (2016).
pubmed: 27385014 pmcid: 5004905
Reichel, C. A. et al. CC motif chemokine CCL3 and canonical neutrophil attractants promote neutrophil extravasation through common and distinct mechanisms. Blood 120, 880–890 (2012).
Leon, C. et al. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion. Blood 110, 3183–3191 (2007).
pubmed: 17664350
Rossaint, J. et al. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap mediated sterile inflammation. Blood 123, 2573–2584 (2014).
Boulaftali, Y. et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J. Clin. Invest. 123, 908–916 (2013).
Labelle, M., Begum, S. & Hynes, R. O. Platelets guide the formation of early metastatic niches. Proc. Natl Acad. Sci. USA 111, E3053–E3061 (2014).
pubmed: 25024172 pmcid: 4121772
Casanova-Acebes, M. et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153, 1025–1035 (2013).
pubmed: 23706740 pmcid: 4128329
Pircher, J. et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat. Commun. 9, 1523 (2018).
pubmed: 29670076 pmcid: 5906636
Stark, K. et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435–2449 (2016).
von Bruhl, M. L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819–835 (2012).
Moy, V. T., Florin, E. L. & Gaub, H. E. Intermolecular forces and energies between ligands and receptors. Science 266, 257–259 (1994).
pubmed: 7939660
Kim, O. V., Litvinov, R. I., Alber, M. S. & Weisel, J. W. Quantitative structural mechanobiology of platelet-driven blood clot contraction. Nat. Commun. 8, 1274 (2017).
pubmed: 29097692 pmcid: 5668372
BD Biosciences. Platelet Activation. BD Biosciences,  https://www.bdbiosciences.com/en-us/applications/research-applications/multicolor-flow-cytometry/platelet-activation (2018).
Petzold, T. et al. Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis. Sci. Transl. Med. 8, 367ra168 (2016).
pubmed: 27903864
Flevaris, P. et al. Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK–dependent integrin outside-in retractile signaling pathway. Blood 113, 893–901 (2009).
pubmed: 18957688 pmcid: 2630274
Müller, J. P. et al. Force sensing by the vascular protein von Willebrand factor is tuned by a strong intermonomer interaction. Proc. Natl Acad. Sci. USA 113, 1208–1213 (2016).
pubmed: 26787887 pmcid: 4747740
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772
Pincus, Z. & Theriot, J. A. Comparison of quantitative methods for cell-shape analysis. J. Microsc. 227, 140–156 (2007).
pubmed: 17845709
Helmuth, J. A., Paul, G. & Sbalzarini, I. F. Beyond co-localization: inferring spatial interactions between sub-cellular structures from microscopy images. BMC Bioinformatics 11, 372 (2010).
pubmed: 20609242 pmcid: 2919515
Shivanandan, A., Radenovic, A. & Sbalzarini, I. F. MosaicIA: an ImageJ/Fiji plugin for spatial pattern and interaction analysis. BMC Bioinformatics 14, 349 (2013).
pubmed: 24299066 pmcid: 4219334

Auteurs

Leo Nicolai (L)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80802, Munich, Germany.

Karin Schiefelbein (K)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Silvia Lipsky (S)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Alexander Leunig (A)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Marie Hoffknecht (M)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Kami Pekayvaz (K)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Ben Raude (B)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Charlotte Marx (C)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Andreas Ehrlich (A)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Joachim Pircher (J)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Zhe Zhang (Z)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Inas Saleh (I)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Anna-Kristina Marel (AK)

Ludwig-Maximilians-Universität, 80799, Munich, Germany.

Achim Löf (A)

Ludwig-Maximilians-Universität, 80799, Munich, Germany.

Tobias Petzold (T)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Michael Lorenz (M)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Konstantin Stark (K)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Robert Pick (R)

Walter-Brendel-Centre of Experimental Medicine, University Hospital, München, Germany.
Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Planegg-Martinsried, Munich, Germany.

Gerhild Rosenberger (G)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Ludwig Weckbach (L)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.

Bernd Uhl (B)

Department of Otorhinolarynology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Sheng Xia (S)

Department of Cell Biology, Johns Hopkins University School of Medicine, 855 North Wolfe Street, Baltimore, MD, 21205, USA.

Christoph Andreas Reichel (CA)

Department of Otorhinolarynology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

Barbara Walzog (B)

Walter-Brendel-Centre of Experimental Medicine, University Hospital, München, Germany.
Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Planegg-Martinsried, Munich, Germany.

Christian Schulz (C)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80802, Munich, Germany.

Vanessa Zheden (V)

Institute of Science and Technology (IST) Austria, 3400, Klosterneuburg, Austria.

Markus Bender (M)

Institute of Experimental Biomedicine I, University Hospital and Rudolf Virchow Center, Würzburg, Germany.

Rong Li (R)

Department of Cell Biology, Johns Hopkins University School of Medicine, 855 North Wolfe Street, Baltimore, MD, 21205, USA.

Steffen Massberg (S)

Medizinische Klinik und Poliklinik I, Klinikum der Ludwig-Maximilians-Universität, 81377, Munich, Germany. steffen.massberg@med.uni-muenchen.de.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80802, Munich, Germany. steffen.massberg@med.uni-muenchen.de.

Florian Gaertner (F)

DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80802, Munich, Germany. florian.gaertner@ist.ac.at.
Institute of Science and Technology (IST) Austria, 3400, Klosterneuburg, Austria. florian.gaertner@ist.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH